Moreover, it was observed that patients in a ‘high LRG1’ group (with median expression used as the cut‐off) were twice as likely to develop HF in the future, and within a shorter amount of time [peptide 1: odds ratio (OR) 2.345 95%CI (1.456–3.775) P = 0.000; peptide 2: OR 2.264 95% CI (1.422–3.605), P = 0.001] (Figure3). This evidence concerns the gene LRG1 and hydrops fetalis.